Clinical Trial Update: Reduced Dose of Cyclophosphamide Combined With Standard Immunosuppressive Therapy to Treat Severe Aplastic Anemia [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating a reduced-dose cyclophosphamide regimen combined with standard immunosuppressive therapy for severe aplastic anemia and i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aplastic Anemia

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)

Snippet

Sponsor: Institute of Hematology & Blood Diseases Hospital, China | Conditions: Severe Aplastic Anemia, Cyclophosphamide Reduced-dose | Phase 2 | Status: RECRUITING